முடிவு கண்டறியும் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from முடிவு கண்டறியும். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In முடிவு கண்டறியும் Today - Breaking & Trending Today

Decision Diagnostics Saga Continues As Investors Bring Suit - Corporate/Commercial Law


To print this article, all you need is to be registered or login on Mondaq.com.
In December, the SEC filed a 
complaint against Decision Diagnostics and its CEO, Keith
Berman, for falsely claiming the company had developed a finger
prick blood test that could instantaneously detect COVID-19. 
As stated in its complaint, the SEC temporarily suspended trading
of Decision Diagnostics securities on April 23, 2020.
Now, investors have brought
suit as well.  Three institutional investors 
claim the company – which was already in financial
distress as a result of 
alleged misappropriations by Berman – falsely
disclosed it was developing an at-home COVID-19 test nearing ....

Decision Diagnostics , Decision Diagnostic , Decision Diagnostics Saga Continues As Investors Bring Suit , Coronavirus Covid 19 , Operational Impacts And Strategy , Corporate Commercial Law , Corporate And Company Law , முடிவு பரிசோதனை , முடிவு கண்டறியும் , முடிவு பரிசோதனை சாகா தொடர்கிறது என முதலீட்டாளர்கள் கொண்டு வாருங்கள் வழக்கு , செயல்பாட்டு தாக்கங்கள் மற்றும் மூலோபாயம் , பெருநிறுவன வணிகரீதியானது சட்டம் , பெருநிறுவன மற்றும் நிறுவனம் சட்டம் ,

Decision Diagnostics Saga Continues as Investors Bring Suit | Proskauer - Corporate Defense and Disputes

Decision Diagnostics Saga Continues as Investors Bring Suit | Proskauer - Corporate Defense and Disputes
jdsupra.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jdsupra.com Daily Mail and Mail on Sunday newspapers.

Keith Berman , Decision Diagnostics , Decision Diagnostic , கேய்ட் பெர்மன் , முடிவு பரிசோதனை , முடிவு கண்டறியும் ,

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Decision Diagnostics Corporation of Class Action Lawsuit and Upcoming Deadline


Share this article
Share this article
NEW YORK, March 12, 2021 /PRNewswire/  Pomerantz LLP announces that a class action lawsuit has been filed against Decision Diagnostics Corporation ( Decision Diagnostics or the Company ) (OTCMKTS: DECN) and certain of its officers. The class action, filed in United States District Court for the Central District of California, and docketed under 21-cv-00418, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Decision Diagnostics securities between March 3, 2020 and December 17, 2020, both dates inclusive (the Class Period ), seeking to recover damages caused by Defendants violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the Exchange Act ) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials. ....

New York , United States , France General , Los Angeles , Abrahaml Pomerantz , Roberts Willoughby , United States District Court , Decision Diagnostics Corporation , Securities Exchange , Drug Administration , Pomerantz Firm , Central District , Decision Diagnostics , Securities Exchange Act , Class Period , Lead Plaintiff , Decision Diagnostic , Pomerantz Llp , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , பிரான்ஸ் ஜநரல் , லாஸ் ஏஞ்சல்ஸ் , ராபர்ட்ஸ் விருப்பம் , ஒன்றுபட்டது மாநிலங்களில் மாவட்டம் நீதிமன்றம் , முடிவு பரிசோதனை நிறுவனம் , பத்திரங்கள் பரிமாற்றம் ,